You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Litigation Details for Genentech, Inc. v. Micro Labs Ltd. (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Genentech, Inc. v. Micro Labs Ltd. (D. Del. 2019)

Docket ⤷  Try a Trial Date Filed 2019-01-17
Court District Court, D. Delaware Date Terminated 2019-10-28
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties INTERMUNE, INC.
Patents 7,566,729; 7,635,707; 7,767,700; 7,816,383; 7,910,610; 8,013,002; 8,084,475; 8,318,780; 8,383,150; 8,420,674; 8,592,462; 8,609,701; 8,648,098; 8,754,109; 8,778,947
Attorneys Ryan Hagglund
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Genentech, Inc. v. Micro Labs Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for Genentech, Inc. v. Micro Labs Ltd. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-01-17 1 Complaint ASSERTED PATENTS  U.S. Patent No. 7,566,729 25. U.S. Patent No. 7,566,729… U.S. Patent No. 7,816,383 31. U.S. Patent No. 7,816,383 (“the ‘383 patent”), entitled… U.S. Patent No. 8,084,475 37. U.S. Patent No. 8,084,475 (“the ‘475 patent”), entitled… U.S. Patent No. 8,420,674 43. U.S. Patent No. 8,420,674 (“the ‘674 patent”), entitled… U.S. Patent No. 8,609,701 47. U.S. Patent No. 8,609,701 (“the ‘701 patent”), entitled External link to document
2019-10-29 18 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1; 7,635,707 B1; 7,767,700…2019 28 October 2019 1:19-cv-00111 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-01-17 3 ANDA Form 12/18/2027 8,420,674 12/18/2027 7,566,729 4/22/2029 7,635,707 4/22/2029… of 2 PageID #: 265 Asserted Patents and Expiration Dates: Patent No. Expiration 8,383,150… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: 12/8/18. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 4/15/… ) SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.